Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_00822 |
| Species: | Homo sapiens |
| Position : | chr11:5225000-5227000 |
| Year: | 2016 |
| Title: | Utility of next-generation RNA-sequencing in identifying chimeric transcription involving human endogenous retroviruses |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| Disease Name: | -- |
| PMID: | 26818267 |
| MONDO: | |
| Tissue: | Bone Marrow |
| Tissue Ontology ID: | UBERON:0002371 |
| Cell Source: | CD34+ cell |
| CVCL ID: | |
| Cell Type: | CD34-positive hematopoietic stem cell |
| Cell Ontology ID: | CL:0001029 |
| Experiment Type: | Chromatin interaction assay |
| High Throughput Method: | ChIP-seq, Hi-C |
| Low Throughput Method: | 3C assay |
| Target gene : | HBB |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_00972 | chr11:5224750-5226210 | Bladder | bladder carcinoma cell | bladder carcinoma |
| E_00974 | chr11:5224750-5226210 | Bone Marrow | chronic myeloid leukemia cell | chronic myeloid leukemia |
| E_00320 | chr11:5225000-5225500 | Embryonic Kidney | embryonic kidney cell | -- |
| E_00954 | chr11:5225000-5227000 | Breast | breast carcinoma cell | breast carcinoma |
| E_00973 | chr11:5225400-5225774 | Bone Marrow | chronic myeloid leukemia cell | chronic myeloid leukemia |
| E_01279 | chr11:5226889-5226999 | Bone marrow | CD34-positive hematopoietic stem cell | -- |